What Trump’s “Big, Beautiful Bill” Means for Healthcare

President Trump’s recently signed the “Big, Beautiful Bill” could have an interesting impact on startups, investors, and the healthcare ecosystem.

A recent Pitchbook article highlighted how the bill makes some tax breaks for small businesses permanent, including a major benefit called QSBS (Qualified Small Business Stock), which lets founders and early investors in certain startups avoid paying taxes on some gains if they hold stock long enough. The 20% pass-through deduction is also here to stay, helping LLCs and S-corps save more on their taxes.

For startup founders, this means better incentives to build and scale.

For VCs, especially those investing early, it improves the potential for returns. It also helps to remove some uncertainty about future tax changes.

The bill cuts back on clean-energy funding and increases tariffs, which could be an obstacle for climate tech and hardware startups to grow. As a result, investors may start shifting more money toward healthcare, AI, software, and defense.

Impact on Healthcare Startups and VCs

Healthcare startups face a mixed bag. The bill supports R&D by restoring full tax write-offs for research expenses, which is a big help to biotech and medtech companies in early stages. It also includes cuts to Medicaid, which could leave people without coverage. This can be a challenge for healthcare startups that rely on patient volume and reimbursement.

Startups that help reduce healthcare costs or use AI to improve diagnostics could see increased investor interest. And because the bill favors business-friendly policies overall, VCs in the healthcare space may find it easier to fund and scale companies that align with this new landscape, especially those focused on prevention, early detection, or cash-pay models.

What Founders and VCs Should Do Now

If you’re a founder, it’s a good time to look at how your company is structured, because you might benefit from becoming a C-corp to take advantage of QSBS. If you’re an investor, think about how these incentives change the risk-reward profile of certain sectors.

Overall, healthcare and deep tech seem like sectors that will benefit most from the bill. As always, shifts in federal policy create new challenges and new opportunities, and those who adapt quickly will be best positioned to thrive.

The Rural Hospital Crisis: A Tipping Point

One of the most dramatic impacts of the new bill will be on rural hospitals. These facilities already operate on razor-thin margins, and they rely heavily on Medicaid and Medicare reimbursements to survive. The bill proposes over $1 trillion in cuts to federal health spending over the next decade, $155 billion of which would directly impact rural communities. These hospitals could lose over $70 billion in reimbursements, just from the Medicaid reductions alone.

With more than 700 rural hospitals now at risk of closure, including over 300 facing immediate financial danger, the consequences could be severe. Many of these hospitals are the only source of care for miles. Cuts to Medicaid expansion, new work requirements, and stricter eligibility reviews mean millions could lose coverage, leaving hospitals to shoulder even more uncompensated care. While a $50 billion rural relief fund has been introduced, it only lasts five years and covers a fraction of the projected losses. States like Texas, Kansas, Alabama, and Mississippi, many of which did not fully expand Medicaid, will be hit the hardest.

Closing Thoughts: Policy Brings Pressure and Possibility

Federal policy shifts always reshape the landscape for founders, funders, and healthcare providers. While the new bill creates opportunities through tax incentives and deregulation, it also introduces major challenges, especially in healthcare delivery and access. For investors and operators alike, the ability to adapt, innovate, and plan strategically around these changes will determine who thrives in this new environment.